Cell-surface peptidases

被引:82
作者
Mentlein, R [1 ]
机构
[1] Univ Kiel, Dept Anat, D-24098 Kiel, Germany
来源
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 235 | 2004年 / 235卷
关键词
plasma membrane; protease; peptide hormones; neuropeptides;
D O I
10.1016/S0074-7696(04)35004-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cell surface has various functions: communicating with other cells, integrating into the tissue, and interacting with the extracellular matrix. Proteases play a key role in these processes. This review focuses on cell-surface peptidases (ectopeptidases, oligopeptidases) that are involved in the inactivation or activation of extracellular regulatory peptides, hormones, paracrine peptides, cytokines, and neuropeptides. The nomenclature of cell-surface peptidases is explained in relation to other proteases, and information is provided on membrane anchoring, catalytic sites, regulation, and, in particular, on their physiological and pharmacological importance. Furthermore, nonenzymatic (binding) functions and participation in intracellular signal transduction of cell surfaces peptidases are described. An overview on the different cell-surface peptidases is given, and their divergent functions are explained in detail. An example of actual pharmacological importance, dipeptidyl-peptidase IV (CD26), is discussed. (C) 2004 Elsevier Inc.
引用
收藏
页码:165 / +
页数:50
相关论文
共 202 条
  • [1] Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
    Abbott, CA
    Yu, DMT
    Woollatt, E
    Sutherland, GR
    McCaughan, GW
    Gorrell, MD
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6140 - 6150
  • [2] GENOMIC ORGANIZATION, EXACT LOCALIZATION, AND TISSUE EXPRESSION OF THE HUMAN CD26 (DIPEPTIDYL PEPTIDASE-IV) GENE
    ABBOTT, CA
    BAKER, E
    SUTHERLAND, GR
    MCCAUGHAN, GW
    [J]. IMMUNOGENETICS, 1994, 40 (05) : 331 - 338
  • [3] Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
    Ahrén, B
    Simonsson, E
    Larsson, H
    Landin-Olsson, M
    Torgeirsson, H
    Jansson, PA
    Sandqvist, M
    Båvenholm, P
    Efendic, S
    Eriksson, JW
    Dickinson, S
    Holmes, D
    [J]. DIABETES CARE, 2002, 25 (05) : 869 - 875
  • [4] [Anonymous], MAMMALIAN PROTEASES
  • [5] Antczak C, 2001, BIOESSAYS, V23, P251, DOI 10.1002/1521-1878(200103)23:3<251::AID-BIES1035>3.3.CO
  • [6] 2-F
  • [7] Antczak C, 2001, J BIOL REG HOMEOS AG, V15, P130
  • [8] DIPEPTIDYL PEPTIDASE-IV EXPRESSION IDENTIFIES A FUNCTIONAL SUBPOPULATION OF BREAST FIBROBLASTS
    ATHERTON, AJ
    MONAGHAN, P
    WARBURTON, MJ
    ROBERTSON, D
    KENNY, AJ
    GUSTERSON, BA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (01) : 15 - 19
  • [9] Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes
    Augustyns, K
    Van der Veken, P
    Senten, K
    Haemers, A
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (04) : 499 - 510
  • [10] Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II
    Barinka, C
    Rinnová, M
    Sácha, P
    Rojas, C
    Majer, P
    Slusher, BS
    Konvalinka, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (03) : 477 - 487